Cargando…
Clinical and biochemical characteristics of 12 Chinese primary hypertrophic osteoarthropathy patients with HPGD mutations
Primary hypertrophic osteoarthropathy (PHO) is a rare genetic disease mainly affecting the skeletal and skin. Two genes involved in prostaglandin degradation are known to be responsible for PHO: HPGD and SLCO2A1. HPGD gene mutation can cause PHO autosomal recessive 1 (PHOAR1). The purpose of the pre...
Autores principales: | Lu, Qi, Xu, Yang, Li, Shanshan, Zhang, Zeng, Sheng, Jiagen, Zhang, Zhenlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254467/ https://www.ncbi.nlm.nih.gov/pubmed/35813463 http://dx.doi.org/10.7150/ijbs.71261 |
Ejemplares similares
-
The first case of primary hypertrophic osteoarthropathy with soft tissue giant tumors caused by HPGD loss-of-function mutation
por: Pang, Qianqian, et al.
Publicado: (2019) -
Primary hypertrophic osteoarthropathy: genetics, clinical features and management
por: Lu, Qi, et al.
Publicado: (2023) -
Case report: Novel homozygous HPGD variant leads to primary hypertrophic osteoarthropathy with intussusception and acro-osteolysis in a Chinese family
por: Liu, Yi, et al.
Publicado: (2023) -
Primary Hypertrophic Osteoarthropathy With Myelofibrosis
por: Yousaf, Muhammad, et al.
Publicado: (2022) -
Hypertrophic Osteoarthropathy
por: Kojima, Hiroki, et al.
Publicado: (2022)